Atlas Trials

Lisata Therapeutics, Inc.

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lisata Therapeutics, Inc.

RecordFirmDate
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC (NCT06592664)Lisata Therapeutics, Inc.2030-01-01
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors (NCT05712356)Lisata Therapeutics, Inc.2023-05-13
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM) (NCT04990427)Lisata Therapeutics, Inc.2022-01-10
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction (NCT04614467)Lisata Therapeutics, Inc.2020-10-29
CLBS119 for Repair of COVID-19 Induced Pulmonary Damage (NCT04522817)Lisata Therapeutics, Inc.2020-10-05
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer (NCT03517176)Lisata Therapeutics, Inc.2018-07-31
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease (NCT03508609)Lisata Therapeutics, Inc.2018-04-19
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) (NCT02501018)Lisata Therapeutics, Inc.2017-11-01

Track Lisata Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.